Increased Mortality Among Persons Infected With Hepatitis C Virus

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 1, 2011, Pages 71-78

  Omland, Lars Haukali ^a   Jepsen, Peter ^b   Krarup, Henrik ^c   Schønning, Kristian ^d   Lind, Bent ^e   Kromann Andersen, Hans ^f   Homburg, Keld Mikkelsen ^g   Christensen, Peer Brehm ^h   Sørensen, Henrik Toft ^b,i   Obel, Niels ^a  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e Laboratory of Copenhagen General Practitioners   (Denmark)

^f KØGE HOSPITAL   (Denmark)

^g NAESTVED HOSPITAL   (Denmark)

^h ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁱ BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Epidemiology; Liver Disease; Mortality

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; REGRESSION ANALYSIS; RISK FACTOR; SURVIVAL RATE;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; DENMARK; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 78650254065     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.09.014     Document Type: Article

References (38)

1. Bell B.P., Manos M.M., Zaman A., et al. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol 2008, 103:2727-2736.
2. Poynard T., Yuen M.F., Ratziu V., et al. Viral hepatitis C. Lancet 2003, 362:2095-2100.
3. Amin J., Law M.G., Bartlett M., et al. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006, 368:938-945.
4. Harris H.E., Ramsay M.E., Andrews N., et al. Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 2002, 324:450-453.
5. Neal K.R., Ramsay S., Thomson B.J., et al. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. Gut 2007, 56:1098-1104.
6. Prasad L., Spicher V.M., Negro F., et al. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study. J Viral Hepat 2009, 16:644-649.
7. Seeff L.B., Miller R.N., Rabkin C.S., et al. 45-Year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000, 132:105-111.
8. Seeff L.B., Hollinger F.B., Alter H.J., et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. J Hepatol 2001, 33:455-463.
9. Cooper C.L. Obstacles to successful HCV treatment in substance addicted patients. J Addict Dis 2008, 27:61-68.
10. Singal A.K., Anand B.S. Mechanisms of synergy between alcohol and hepatitis C virus. J Clin Gastroenterol 2007, 41:761-772.
11. Population and elections Statistics Denmark, Accessed: June 1, 2010. http://www.statistikbanken.dk/statbank5a/default.asp?w=1280.
12. Guide to the prevention of viral hepatitis [Danish] The National Board of Health, Accessed: June 1, 2010. http://www.sst.dk/publ/Publ2002/hepatitis/html/index.htm.
13. Lettmeier B., Muhlberger N., Schwarzer R., et al. Market uptake of new antiviral drugs for the treatment of hepatitis C. J Hepatol 2008, 49:528-536.
14. Frank L. Epidemiology. When an entire country is a cohort. Science 2000, 287:2398-2399.
15. Omland L.H., Krarup H., Jepsen P., et al. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study. J Hepatol 2010, 53:36-42.
16. Krarup H.B., Drewes A.M., Madsen P.H. A quantitative HCV-PCR test for routine diagnostics. Scand J Clin Lab Invest 1998, 58:415-422.
17. The National Patient Registry The National Board of Health, Accessed: June 1, 2010. http://www.sst.dk/Informatik_og_sundhedsdata/Registre_og_sundhedsstatistik/Beskrivelse_af_registre/Landspatientregister.aspx?lang=en.
18. Juel K., Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999, 46:354-357.
19. The Registry of Drug Abusers Undergoing Treatment The National Board of Health, Accessed: June 1, 2010. http://sst.dk/Informatik_og_sundhedsdata/Registre_og_%20sundhedsstatistik/Beskrivelse_af_registre/Stofmisbrugerregister.aspx?lang=en.
20. The integrated database for labour market research Statistics Denmark, Accessed: June 1, 2010. http://www.dst.dk/HomeUK/Guide/documentation/Varedeklarationer/emnegruppe/emne.aspx?sysrid=1013.
21. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
22. Sundararajan V., Henderson T., Perry C., et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004, 57:1288-1294.
23. Quan H., Sundararajan V., Halfon P., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43:1130-1139.
24. Kleinbaum D.G., Klein M. Competing risk survival analysis. Survival analysis: a self-learning text 2005, 391-461. Springer Science + Business Media, LLC, New York, New York. 2nd ed.
25. Rothman K.J., Greenland S., Lash T.L. Validity in epidemiologic studies. Modern epidemiology 2008, 128-147. Lippincott Williams & Wilkins, New York, New York. 3rd ed. K.J. Rothman, S. Greenland, T.L. Lash (Eds.).
26. Bruno S., Stroffolini T., Colombo M., et al. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology 2007, 45:579-587.
27. Greenland S., Rothman K.J. Introduction to stratified analysis. Modern epidemiology 2008, 258-282. Lippincott Williams & Wilkins, Philadelphia, PA. 3rd ed. K.J. Rothman, S. Greenland, T.L. Lash (Eds.).
28. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin [Irish]. N Engl J Med 1999, 340:1228-1233. Hepatology Research Group.
29. Wiese M., Grungreiff K., Guthoff W., et al. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany-a 25-year multicenter study. J Hepatol 2005, 43:590-598.
30. van Oort F.V., van Lenthe F.J., Mackenbach J.P. Material, psychosocial, and behavioural factors in the explanation of educational inequalities in mortality in The Netherlands. J Epidemiol Community Health 2005, 59:214-220.
31. Skalická V., van Lenthe F., Bambra C., et al. Material, psychosocial, behavioural and biomedical factors in the explanation of relative socio-economic inequalities in mortality: evidence from the HUNT study. Int J Epidemiol 2009, 38:1272-1284.
32. Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997, 349:825-832. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
33. Zarski J.P., Mc Hutchison J., Bronowicki J.P., et al. Rate of natural disease progression in patients with chronic hepatitis C. J Hepatol 2003, 38:307-314.
34. Thomas D.L., Astemborski J., Rai R.M., et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000, 284:450-456.
35. Kim W.R., Gross J.B., Poterucha J.J., et al. Outcome of hospital care of liver disease associated with hepatitis C in the United States. Hepatology 2001, 33:201-206.
36. Perlemuter G., Letteron P., Carnot F., et al. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J Hepatol 2003, 39:1020-1027.
37. Rigamonti C., Mottaran E., Reale E., et al. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 2003, 38:42-49.
38. Jepsen P., Vilstrup H., Andersen P.K., et al. Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology 2008, 48:214-220.